Author name: zascorporation

In a groundbreaking alliance, ZAS and OM Pharma recently convened a meeting attended by industry leaders and visionaries, setting the stage for a dynamic partnership in healthcare innovation. The event featured a compelling address from OM Pharma’s Executive Chairman, Etienne Jornod, who eloquently outlined the shared commitment of both entities to revolutionize the healthcare landscape.

ZAS Pharma Ltd. proudly observes Epilepsy Awareness Month in November 2023, collaborating with the esteemed doctors of Bangabandhu Sheikh Mujib Medical University through their ‘Named Patient Access’ initiative. In a collective effort, they aim to heighten awareness about rare diseases, offering crucial support to those facing these challenges. Heartfelt gratitude is extended to the dedicated

The conclusion of CPHI Barcelona signifies not just the end of an event but the dawn of exciting new opportunities for ZAS. This milestone marks the commencement of a journey filled with intensive networking and productivity, solidifying powerful connections with industry innovators. With an expanded global network as a foundation, ZAS is now strategically positioned

ZAS marked a historic milestone by hosting the inaugural Scientific Session at Hotel Radisson Blu Dhaka, focusing on the preventive potential of Lyophilized Bacterial Lysates for Recurrent Respiratory Tract Infections. The event showcased the newly launched Broncho-Vaxom, a revolutionary lyophilized bacterial lysate with a precise 7mg dosage. Attended by distinguished ICU, Respiratory Medicine, Pediatrician, and

In a significant stride towards advancing eye healthcare, Md. Zahidul Islam, the Managing Director of ZAS Pharma Ltd., recently participated in the 14th Annual National Conference of the Bangladesh Glaucoma Society (BGS) held in Vietnam. The event served as a pivotal platform for professionals and experts in the field of ophthalmology to exchange knowledge and